EnteraSense secured $4 million (€3.5 million) in funding for its gastrointestinal tract bleed-detecting capsule, Med-Tech Innovation News reports.
Here's what you should know:
1. The capsule monitors unexpected bleeding in postsurgical patients.
2. If a physician suspects GI bleeding, the capsule detects it quickly.
3. EnteraSense won a European Union Horizon 2020 grant and secured private investor funding.
4. EnteraSense will conduct in-human studies in 2019, with the goal of earning regulatory approval in 2020.